Inventor

DAPPEN MICHAEL S

US26 patents

⚠️ This page may combine multiple inventors who share the name “DAPPEN MICHAEL S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DAPPEN MICHAEL S

SEARLE & CO

Opioid agonist compounds

Opioid agonist compounds

Benzimidazole compounds

Method of using opioid compounds as delta opioid selective agonist analgesics

Benzimidazole compounds

Opioid agonist compounds

Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders

ATHENA NEUROSCIENCES INC

Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4

Identification of phospholipase A2 inhibitors in Aβ peptide-mediated neurodegenerative disease

Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4

Inhibition of phospholipase A2 to reduce neuronal cell death

ELAN PHARM INC

Sulfonylquinoxalone derivatives as bradykinin antagonists

Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists

Substituted pyrimidine compositions and methods of use

N-substituted benzene sulfonamides

Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists

N-substituted benzene sulfonamides

KONRADI ANDREI W

Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds

Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds

N-sulfonamido polycyclic pyrazolyl compounds

WYETH CORP

Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

(unassigned)

Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4

C D SEARLE & CO

Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders